List of findings

Use the filters on the left to narrow down the list of findings, or use "Browse by keyword" on the right to locate a specific finding.

Heroin and morphine seizures remain concentrated in Asia.In line with the concentration of opium production in Asia, almost two thirds (64 per cent) of global heroin and morphine seizures occurred in Asia in 2024, notably in South-Western Asia and, to a lesser extent, in East and South-East Asia.In…
Seizures of key pharmaceutical opioids show distinct regional patterns by substance.While fentanyl seizures remain overwhelmingly concentrated in North America (> 99 per cent), other pharmaceutical opioids dominate seizures in different regions: codeine in West and Central Africa and South Asia…
Global opioid use has remained broadly stable, with strong regional differences in prevalence of use.The number of people who use opioids worldwide has remained relatively stable in the last five years, with the estimate for 2024 only slightly higher than the level in 2019.Prevalence of past-year…
Global opiate use has remained broadly stable, with slight declines in the prevalence of use.The number of people using opiates worldwide has remained stable over the last five years, while the annual prevalence of use declined slightly from 0.61 per cent in 2020 to 0.57 per cent in 2023 and 2024.…
Myanmar is now the world’s largest opium producer, followed by Afghanistan, Mexico and the Lao People’s Democratic Republic.In Myanmar, opium production continues to be concentrated in the eastern parts of the country, notably in Shan State and in Kachin. This pattern has not changed over the last…
The type of opioid that is most used non-medically varies across regions and countries.With the highest population globally, Asia is also the region with the highest number of people who use opioids.The type of opioid used differs across regions, with opiates such as heroin dominating in Asia and…
The non-medical use and trafficking of tramadol remain most concentrated in North Africa, West and Central Africa, and the Near and Middle East and South-West Asia, though there remains significant localized non-medical use in other regions.There remains a significant data gap on tramadol use and…
The health harms posed by the non-medical use of opioids remains high in North America, but have started to decline in late 2023 and in 2024.Opioid overdose deaths reached historical highs in the United States of America and Canada between 2021 and 2023 but have since started to decline, returning…
In East and South-East Asia, limited regular data collection makes it difficult to assess long-term trends in opioid use. However, data on people registered for drug use and people in drug treatment indicate a decline in opioid (mainly heroin) use over the past 10 to 15 years.In most of East and…
Opioid-related harms, measured as new people entering treatment, have declined in Europe.Although the share of people in treatment for opioid use disorders remains substantial in Europe, the number of people entering treatment for the first time has decreased.In Eastern Europe and South-Eastern…
Opium production and opiate seizures are closely linked, but stockpiling has partly mitigated recent supply shocks.Opiate seizures have generally moved in parallel with opium production over time, but production has been far more volatile. Following the transfer of power in Afghanistan in 2021 and…
Opium prices show diverging trends, reflecting shifting supply dynamics across producing countries.Opium poppy cultivation in Myanmar, increased by 17 per cent in 2025 and more than doubled since 2020, with increases reported across all poppy producing states; this was mirrored by a similar…